In contrast to our results, Sakata et al observed lower PAI-1 activity in APL patients with DIC compared to healthy controls.[45] One possible explanation is that they used an in-house assay to measure PAI-1 activity whereas we used a commercial assay for active PAI-1. Here, SERPINE1 is linked to acute promyelocytic leukemia.